[ad_1] Bausch & Lomb Corp.’s stock soared 10% early Wednesday after the eye-care company reported…
Tag:
ocular implants
-
-
STOCK MARKET
Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a $2.5 billion deal
by userby user[ad_1] Shares of Bausch + Lomb Corp. leapt into record territory Friday, after the eye-health…
-
STOCK MARKET
EssilorLuxottica warns tough economic climate could weigh in coming year, as revenue falls short
by userby user[ad_1] Corrections & Amplifications This headline was corrected at 0609 GMT because the percentage was…
-
STOCK MARKET
After IPO, Bausch + Lomb turns to an industry favorite to run the company
by userby user[ad_1] Bausch + Lomb Corp.’s decision to bring back Brent Saunders as CEO hints at…
-
STOCK MARKET
Estée Lauder prevails in auction to buy Tom Ford in deal worth $2.8 billion
by userby user[ad_1] Estée Lauder Cos. EL, +2.86% will acquire Tom Ford in a deal valued at…
-
STOCK MARKET
EssilorLuxottica sales rise thanks to strong Europe sales, China reopening
by userby user[ad_1] EssilorLuxottica SA said Friday that revenue in the third quarter picked up thanks to…
-
[ad_1] Bausch + Lomb Corp. BLCO, priced its IPO at $18 a share Thursday, falling short…
-
STOCK MARKET
U.S. IPO market bracing for second-biggest deal of the year so far in eyecare health company Bausch + Lomb
by userby user[ad_1] The U.S. initial public offering market is bracing for what is expected to be…